Table 2.
Age group (Yr) | Total | Detection rate among all patients (%) | Detection rate among virus-positive patients (%) | |||
---|---|---|---|---|---|---|
0–11 | 2–32** | 4–143* | ||||
FA | 22 | 22 | 70 | 114 | 15.0% | 5.28% |
FB | 8 | 5 | 102 | 115 | 15.13% | 5.32% |
PIV I | 0 | 10 | 19 | 29 | 3.82% | 1.34% |
PIV II | 15 | 5 | 19 | 39 | 5.13% | 1.81% |
PIV III | 0 | 0 | 13 | 13 | 1.71% | 0.60% |
ADV | 15 | 29 | 38 | 82 | 10.79% | 3.80% |
RSV | 183 | 135 | 50 | 368 | 48.42% | 17.04% |
Respiratory viruses detected (%) | 243 (48.99%) | 206 (29.06%) | 311 (32.57%) | 760 (35.19%) | ||
Total cases | 496 | 709 | 955 | 2160 |
Group 1 vs. Group 2 (P<0.01);
Group 1 vs. Group 3 (P<0.05).
RSV – respiratory syncytial virus; FA – influenza virus A; FB – influenza virus B; PIV I – parainfluenza virus I; PIV II – parainfluenza virus II; PIV III – parainfluenza virus III; ADV – adenovirus.